WGS
GeneDx Holdings Corp. Class A Common Stock#1 · 2024EPA+Yearly return
+2811%
Peak return
+3275%
Max drawdown
-40%
ADR (20 days)
+7.6%
Base
24 days / -34.0%
Prior run
+614%
Breakout volume
49.0x
Pivot
$12.57
Catalyst Earnings/Guidance2024-04-29GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsGlobeNewswire Inc.
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare WGS with the current market directly.